The pathogens considered most dangerous to human health included Aspergillus fumigatus, which comes from mold and infects the ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Patients infected with ...

Without immediate action, humanity will potentially face further escalation in resistance in fungal disease, a group of scientists from the around the world has warned. According to the scientists ...

F2G submitted its initial approval application with data from the first 100 patients enrolled in a phase 2b study of the drug ...

Kerassentials is a novel formula designed to combat antifungal resistance and alleviate toenail itching. The formula h ...

F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as ...

The limited number of antimycotics, the obstacles encountered in the development of new drugs due to the poor tolerability of antifungal agents in patients, the limited number of unique antifungal ...

The funding, from AMR Action Fund and others, will help U.K.-based F2G complete late testing of a treatment that the FDA rejected one year ago.